Preemption in product litigation arises where a federal statute or regulatory scheme displaces state tort duties. It may be express, as in the Medical Device Amendments preemption clause, or implied through conflict or impossibility.
The analysis is highly specific to the regulatory pathway and the product category.
Alternative Names:
Product Preemption, Preemption Defense
Why it Matters?
Preemption is the most powerful defense available in regulated product litigation because it eliminates claims rather than reducing them, and it presents a legal question suitable for early motion practice. Outcomes diverge sharply by pathway: premarket approved devices receive broad protection, cleared devices generally do not, and generic drug manufacturers occupy a different position from brand manufacturers.
Frequently Confused with
Related terms
Frequently asked questions
Does regulatory compliance alone establish preemption?
Why do device cases turn on the approval pathway?
